Mednet Logo
HomeRadiation OncologyQuestion

What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?

5
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · NYU Langone

There is no definitive evidence at this time that one of these imaging agents is clearly superior to the other because there are no comparative data in the same patient group.

For Posluma, the potential benefit over Pylarify would be lower bladder excretion allowing for better visualization of the pe...

Register or Sign In to see full answer